Influence of Azilsartan or Olmesartan on renin-angiotensin-aldosterone system.
Not Applicable
- Conditions
- essential hypertension
- Registration Number
- JPRN-UMIN000011006
- Lead Sponsor
- Sekino Hospital, Nihon Univ. Itabashi Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients from whom informed consent was not obtained
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method renin, angiotensin, aldosterone
- Secondary Outcome Measures
Name Time Method CG (LVMI, EF) BNP cystatin C, albuminuria, Ox-LDL Blood pressure, heart rate Cr, eGFR ABI, PWV side effect